The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrence

The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrence in patients referred to pediatric nephrology clinic, Imam Reza hospital

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N113

Enrollment

Registered

2019-02-24

Start date

2019-03-06

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic syndrome. Nephrotic syndrome

Interventions

Intervention 1: The intervention group will receive MMF in a dose of 600 mg / m2 every 12 hours. Corticosteroid dose of 60mg / m2 increases for three consecutive days until negative proteinuria. Inter

Eligibility

Sex/Gender

All

Age

1 Years to 12 Years

Inclusion criteria

Inclusion criteria: Ages 1 to 12 years

Exclusion criteria

Exclusion criteria: Patients who have been treated with MMF for at least 6 months

Design outcomes

Primary

Measure	Time frame
Digestive complications. Timepoint: The beginning, end of the study and every three months. Method of measurement: Asking the patient.;Infection. Timepoint: The beginning and end of the study. Method of measurement: Doctor's observation.;Leukopenia. Timepoint: The beginning and end of the study. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Rafati

Kermanshah University of Medical Sciences

mrafati41@yahoo.com+98 83 3427 6306

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026